发明名称 Pharmaceutical for treatment of hypertonia - contains selenium, thus also compensating for selenium deficiency
摘要 Pharmaceutical for the treatment of hypertonia contains selenium and conventional auxilliaries and carriers. The selenium can be present as an inorganic and/or organic cpd. Sodium selenite is the pref. inorganic cpd., while pref. organic cpds. are selenium yeast, selenium contg. algae, selenomethionine and/or selenocysteine. Pref. the daily dose of Se is 50-150 micrograms. USE/ADVANTAGE - The pharmaceutical can be used in the treatment of hypertonia (esp. primary hypertonia), while at the same time conpensating for selenium deficiency, one of the symptoms of hypertonia. Selenium is a trace element essential to humans and protects against various forms of liver necroses. It is a component of glutathione peroxidase, which protects red blood cells from peroxides.
申请公布号 DE3628010(A1) 申请公布日期 1988.02.25
申请号 DE19863628010 申请日期 1986.08.19
申请人 ASTRA CHEMICALS GMBH, 2000 HAMBURG, DE 发明人 LUDWIG, GERHARD, DR., 6534 STROMBERG, DE;KREUZER, TILMAN, 2000 HAMBURG, DE;FEULNER, ANDREAS, 2000 WEDEL, DE
分类号 A61K33/04;(IPC1-7):A61K33/04 主分类号 A61K33/04
代理机构 代理人
主权项
地址